Cancer-specific loss of TERT activation sensitizes glioblastoma to DNA damage
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cancer-specific loss of TERT activation sensitizes glioblastoma to DNA damage
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 118, Issue 13, Pages e2008772118
Publisher
Proceedings of the National Academy of Sciences
Online
2021-03-24
DOI
10.1073/pnas.2008772118
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Liposome Imaging in Optically Cleared Tissues
- (2020) Abdullah Muhammad Syed et al. NANO LETTERS
- Mesenchymal and MAPK Expression Signatures Associate with Telomerase Promoter Mutations in Multiple Cancers
- (2020) Josh Lewis Stern et al. MOLECULAR CANCER RESEARCH
- Targeting telomerase for cancer therapy
- (2020) Adam N. Guterres et al. ONCOGENE
- CRISPR-Cas9 Circular Permutants as Programmable Scaffolds for Genome Modification
- (2019) Benjamin L. Oakes et al. CELL
- Principles of Resistance to Targeted Cancer Therapy: Lessons from Basic and Translational Cancer Biology
- (2019) Amit J. Sabnis et al. TRENDS IN MOLECULAR MEDICINE
- Length‐independent telomere damage drives post‐mitotic cardiomyocyte senescence
- (2019) Rhys Anderson et al. EMBO JOURNAL
- Interaction of BRAF-induced ETS factors with mutant TERT promoter in papillary thyroid cancer
- (2019) Young Shin Song et al. ENDOCRINE-RELATED CANCER
- Mechanisms underlying the activation of TERT transcription and telomerase activity in human cancer: old actors and new players
- (2019) Xiaotian Yuan et al. ONCOGENE
- Assessing micrometastases as a target for nanoparticles using 3D microscopy and machine learning
- (2019) Benjamin R. Kingston et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Quantifying the Ligand-Coated Nanoparticle Delivery to Cancer Cells in Solid Tumours
- (2018) Qin Dai et al. ACS Nano
- Disruption of the β1L Isoform of GABP Reverses Glioblastoma Replicative Immortality in a TERT Promoter Mutation-Dependent Manner
- (2018) Andrew Mancini et al. CANCER CELL
- Systematic discovery of natural CRISPR-Cas12a inhibitors
- (2018) Kyle E. Watters et al. SCIENCE
- Prediction of potent shRNAs with a sequential classification algorithm
- (2017) Raphael Pelossof et al. NATURE BIOTECHNOLOGY
- GuideScan software for improved single and paired CRISPR guide RNA design
- (2017) Alexendar R Perez et al. NATURE BIOTECHNOLOGY
- Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
- (2017) Ahmet Zehir et al. NATURE MEDICINE
- Mutations in the promoter of the telomerase geneTERTcontribute to tumorigenesis by a two-step mechanism
- (2017) Kunitoshi Chiba et al. SCIENCE
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- Mutant IDH1 Expression Drives TERT Promoter Reactivation as Part of the Cellular Transformation Process
- (2016) Shigeo Ohba et al. CANCER RESEARCH
- Cornerstones of CRISPR–Cas in drug discovery and therapy
- (2016) Christof Fellmann et al. NATURE REVIEWS DRUG DISCOVERY
- Short-term inhibition of TERT induces telomere length-independent cell cycle arrest and apoptotic response in EBV-immortalized and transformed B cells
- (2016) Andrea Celeghin et al. Cell Death & Disease
- Therapeutic Targeting of Telomerase
- (2016) Kathrin Jäger et al. Genes
- Mutation of theTERTpromoter, switch to active chromatin, and monoallelicTERTexpression in multiple cancers
- (2015) Josh Lewis Stern et al. GENES & DEVELOPMENT
- Non-canonical NF-κB signalling and ETS1/2 cooperatively drive C250T mutant TERT promoter activation
- (2015) Yinghui Li et al. NATURE CELL BIOLOGY
- A Pilot Study of the Telomerase Inhibitor Imetelstat for Myelofibrosis
- (2015) Ayalew Tefferi et al. NEW ENGLAND JOURNAL OF MEDICINE
- The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer
- (2015) R. J. A. Bell et al. SCIENCE
- Cancer-associated TERT promoter mutations abrogate telomerase silencing
- (2015) Kunitoshi Chiba et al. eLife
- Noncanonical Functions of Telomerase: Implications in Telomerase-Targeted Cancer Therapies
- (2014) Yinghui Li et al. CANCER RESEARCH
- Easy quantitative assessment of genome editing by sequence trace decomposition
- (2014) Eva K. Brinkman et al. NUCLEIC ACIDS RESEARCH
- TERT promoter mutations rather than methylation are the main mechanism for TERT upregulation in adult gliomas
- (2013) Hideyuki Arita et al. ACTA NEUROPATHOLOGICA
- Upregulating mutations in the TERT promoter commonly occur in adult malignant gliomas and are strongly associated with total 1p19q loss
- (2013) Hideyuki Arita et al. ACTA NEUROPATHOLOGICA
- Dynamic Imaging of Genomic Loci in Living Human Cells by an Optimized CRISPR/Cas System
- (2013) Baohui Chen et al. CELL
- Genome engineering using the CRISPR-Cas9 system
- (2013) F Ann Ran et al. Nature Protocols
- TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
- (2013) P. J. Killela et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TERT Promoter Mutations in Familial and Sporadic Melanoma
- (2013) S. Horn et al. SCIENCE
- Highly Recurrent TERT Promoter Mutations in Human Melanoma
- (2013) F. W. Huang et al. SCIENCE
- An Optimized microRNA Backbone for Effective Single-Copy RNAi
- (2013) Christof Fellmann et al. Cell Reports
- Wnt/ -Catenin Signaling Regulates Telomerase in Stem Cells and Cancer Cells
- (2012) K. Hoffmeyer et al. SCIENCE
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Functional Identification of Optimized RNAi Triggers Using a Massively Parallel Sensor Assay
- (2011) Christof Fellmann et al. MOLECULAR CELL
- Ebola virus entry requires the cholesterol transporter Niemann–Pick C1
- (2011) Jan E. Carette et al. NATURE
- Telomere dysfunction induces metabolic and mitochondrial compromise
- (2011) Ergün Sahin et al. NATURE
- Toolkit for evaluating genes required for proliferation and survival using tetracycline-regulated RNAi
- (2010) Johannes Zuber et al. NATURE BIOTECHNOLOGY
- H2AX Is Required for Cell Cycle Arrest via the p53/p21 Pathway
- (2009) M. Fragkos et al. MOLECULAR AND CELLULAR BIOLOGY
- Ets2 Maintains hTERT Gene Expression and Breast Cancer Cell Proliferation by Interacting with c-Myc
- (2008) Dakang Xu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Targeting the GA Binding Protein 1L Isoform Does Not Perturb Lymphocyte Development and Function
- (2008) H.-H. Xue et al. MOLECULAR AND CELLULAR BIOLOGY
- -H2AX in recognition and signaling of DNA double-strand breaks in the context of chromatin
- (2008) A. Kinner et al. NUCLEIC ACIDS RESEARCH
- Histone H2AX is a critical factor for cellular protection against DNA alkylating agents
- (2008) J A Meador et al. ONCOGENE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now